Rheumatoid lung disease with rheumatoid arthritis of left hand
ICD-10 M05.142 is a billable code used to indicate a diagnosis of rheumatoid lung disease with rheumatoid arthritis of left hand.
Rheumatoid lung disease is a serious complication of rheumatoid arthritis (RA), characterized by interstitial lung disease, pleural effusions, and pulmonary nodules. Anatomically, the lungs are affected by the systemic inflammatory process of RA, leading to fibrosis and impaired gas exchange. Clinically, patients may present with dyspnea, cough, and decreased exercise tolerance. The left hand involvement indicates that the patient has joint inflammation, typically affecting the metacarpophalangeal and proximal interphalangeal joints, leading to pain, swelling, and potential deformities. The combination of these conditions complicates management, requiring a multidisciplinary approach to address both musculoskeletal and pulmonary symptoms.
Detailed imaging reports (X-rays, MRIs) and functional assessments of the left hand joints are essential for accurate coding.
Patients may require surgical interventions such as synovectomy or joint replacement due to severe deformities.
Documentation should include specific joints affected and the degree of functional impairment.
Inflammatory markers (e.g., ESR, CRP) and disease activity scores (e.g., DAS28) must be documented to assess the severity of RA.
Management of systemic symptoms and coordination of care for lung disease are critical.
Monitoring for disease progression and treatment response is vital for accurate coding.
Functional assessments, including range of motion and strength testing, are necessary to evaluate rehabilitation needs.
Patients may require physical therapy for mobility restoration and pain management.
Documentation should address assistive devices and home modifications needed for patient safety.
Used for follow-up visits assessing both joint and lung symptoms.
Documentation must include history, examination findings, and treatment plan.
Rheumatology and pulmonology considerations for comprehensive care.
Key elements include detailed descriptions of lung involvement, joint symptoms, inflammatory markers, and treatment plans. Documentation should also reflect the severity of both the lung and joint conditions.
